Lung Adenocarcinoma has a Higher Risk of Lymph Node Metastasis than Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
- 90 Downloads
Controversy still exists in which subtype of non-small-cell lung cancer [squamous cell carcinoma (SCC) or adenocarcinoma] is more likely to have lymph node (LN) metastasis. The aim of this study is to compare the pattern of LN metastasis in two cohorts of matched patients surgically treated for SCC or adenocarcinoma.
A retrospective analysis of patients undergoing lobectomy or segmentectomy with systematic lymphadenectomy without preoperative treatment for lung SCC or adenocarcinoma was conducted in this study. Data for analysis consisted of age, gender, tumor size, lobe-specific tumor location, tumor location (peripheral or central), and pathologic findings. We conducted the propensity score-matched (PSM) analysis to eliminate potential bias effects of possible confounding factors.
From January 2015 to December 2016 in our department, we finally included a total of 387 patients (including 63 patients with SCC and 324 patients with adenocarcinoma) for analysis. For the unmatched cohort, there was no sufficient evidence of significantly different number of positive LNs (P = 0.90) and rate of LN metastasis (P = 0.23) between SCC patients and adenocarcinoma patients. However, potential confounding factors, for example gender, tumor size, tumor location, tumor differentiation, and total number of dissected LNs, were significantly different between patients with SCC and those with adenocarcinoma. In the analysis of matched cohort after PSM analysis, those above confounding factors were comparable between the two groups. However, patients with adenocarcinoma had significantly more mean positive LNs (2.2 and 0.7; P = 0.008) and a higher rate of LN metastasis (53% and 29%; P = 0.016) than those with SCC.
Lung adenocarcinoma had a higher risk of LN metastasis than SCC, suggesting that different therapeutic modalities may be indicated for the two different subtypes of lung cancer.
HYD and MZ drafted the manuscript. GL, GA, and JL collected the data. HYD, MZ, LXL, QZ, and YDL revised the manuscript. HYD, GL and YDL designed the study.
This work was supported by National Natural Science Foundation of China [Nos. 31071210; 81672291] (to Yi-Dan Lin).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Asamura H, Chansky K, Crowley J et al (2015) The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 10:1675–1684CrossRefGoogle Scholar
- 7.Saeteng S, Tantraworasin A, Euathrongchit J et al (2012) Nodal involvement pattern in resectable lung cancer according to tumor location. Cancer Manag Res 4(151–15):8Google Scholar
- 19.Sigel CS, Moreira AL, Travis WD et al (2011) Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol 6(1849–185):6Google Scholar
- 20.Haruki T, Aokage K, Miyoshi T et al (2015) Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection. J Thorac Oncol 10(930–93):6Google Scholar
- 21.Wu N, Lv C, Yan S et al (2008) Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns. Interact Cardiovasc Thorac Surg 7(240–24):3Google Scholar
- 22.Koike T, Koike T, Yamato Y et al (2012) Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol 7(1246–125):1Google Scholar
- 25.Lee PC, Port JL, Korst RJ et al (2007) Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 84(177–18):1Google Scholar
- 29.Gupta P, Sharma PK, Mir H et al (2014) CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget 5:10170–10179Google Scholar
- 30.Steuer CE, Behera M, Berry L et al (2016) Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: results from the Lung Cancer Mutation Consortium. Cancer 122(766–77):2Google Scholar